Abstract：
Genitourinary syndrome of menopause (GSM) has a significantly negative impact on affected women\'s lives. However, despite the increasing number of GSM treatment options (e.g. non-hormonal vaginal products, vaginal hormones [estrogens], dehydroepiandrosterone [DHEA; prasterone], vaginal laser therapy, oral ospemifene), many women remain untreated. The goal of the Swiss interdisciplinary GSM consensus meeting was to develop tools for GSM management in daily practice: a GSM management algorithm (personalized medicine); a communication tool for vaginal DHEA (drug facts box); and a communication tool for understanding regulatory authorities and the discrepancy between scientific data and package inserts. The acceptance and applicability of such tools will be further investigated.
摘要：
更年期泌尿生殖系统综合征(GSM)对女性的生活有显著的负面影响。然而,尽管越来越多的GSM治疗选择（例如非激素阴道产品，阴道激素[雌激素]，脱氢表雄酮[DHEA;praestone]，阴道激光治疗，口服奥培米芬)，许多妇女仍未得到治疗。瑞士跨学科GSM共识会议的目标是在日常实践中开发GSM管理工具：GSM管理算法（个性化医疗）；用于阴道DHEA（药物事实框）的通信工具；以及用于了解监管机构以及科学数据与包装之间差异的通信工具。将进一步研究此类工具的接受度和适用性。
